Copyright
©The Author(s) 2023.
World J Clin Cases. Feb 16, 2023; 11(5): 1058-1067
Published online Feb 16, 2023. doi: 10.12998/wjcc.v11.i5.1058
Published online Feb 16, 2023. doi: 10.12998/wjcc.v11.i5.1058
Table 1 Comparison of general information of each group (mean ± SD)
| Group | Gender | Age (yr) | BMI (kg/m2) | |
| Male | Female | |||
| Control (n = 50) | 22 | 28 | 53.25 ± 4.67 | 22.53 ± 3.67 |
| Observation (n = 75) | 38 | 37 | 51.34 ± 7.56 | 23.45 ± 4.23 |
| χ2/t | 0.584 | 1.594 | 1.255 | |
| P value | 0.465 | 0.114 | 0.212 | |
- Citation: Liang JJ, Feng WJ, Li R, Xu RT, Liang YL. Analysis of the value and safety of thyroid-stimulating hormone in the clinical efficacy of patients with thyroid cancer. World J Clin Cases 2023; 11(5): 1058-1067
- URL: https://www.wjgnet.com/2307-8960/full/v11/i5/1058.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i5.1058